Aarhus N

• Fremanezumab for pain in Complex Regional Pain Syndrome Recruiting
  2022-503167-15-00 4 2023-12-11 Complex Regional Pain Syndrome
• Early Initiated Vasopressor Therapy in the Emergency Department - A Multi-center Randomized Controlled Trial (VASOSHOCK) Recruiting
  2023-504584-16-00 5 2023-12-08 Hypotension
• Prophylaxis Study of Marstacimab in Pediatric Hemophilia Participants With or Without Inhibitors Recruiting
  2022-500495-65-00 5 2023-12-06 Haemophilia
• LiBRA – Lithium treatment to prevent cognitive impairment after brain radiotherapy. Recruiting
  2023-504071-24-00 4 2023-11-07 Brain tumor
• Phase 1/2 Study of Oral Nuvisertib (TP-3654) in Patients with Myelofibrosis Recruiting
  2022-502597-16-00 9 2023-10-27 Intermediate or High-risk Primary or Secondary Myelofibrosis
• A randomized phase II study of gemcitabine versus reduced-dose combination chemotherapy in fragile patients with non-resectable pancreatic c … Recruiting
  2024-514291-41-00 4 2023-10-20 Pancreatic cancer
• A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) … Recruiting
  2022-502160-20-00 5 2023-10-02 Idiopathic Immune Complex Mediated Membranoproliferative Glomeruloneph
• The OPTIMIST study Recruiting
  2023-505940-20-00 11 2023-09-26 osteoporosis
• Infliximab for non-Crohn Anal Fistulas Recruiting
  2022-502263-38-00 4 2023-09-01 Anal fistula
• A Study to Evaluate the Efficacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis (ELIXIR) Recruiting
  2024-513562-19-00 5 2023-08-30 End-Stage Kidney Disease
• Does peri-operative treatment with Tranexamic Acid reduce the early relapse rate for patients with melanoma; a randomised controlled trial Recruiting
  2022-502633-26-00 5 2023-08-25 Melanoma Surgery
• CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML) Recruiting
  2023-504999-25-00 5 2023-07-14 Acute Myeloid Leukemia
• Tranexamic acid for hyperacute spontaneous IntraCerebral Haemorrhage (TICH-3) Recruiting
  2022-500587-35-01 5 2023-07-06 Stroke
• HYPATIA: A prospective randomised controlled trial of HYdroxychloroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibod … Recruiting
  2023-504661-23-00 5 2023-06-27 Antiphospholipid antibodies
• Early detection of hepatocellular carcinoma by Hyperpolarized [1- 13C]pyruvate MRI Recruiting
  2024-512490-27-00 4 2023-06-19 Primary liver cancer
• The Danish Out-of-Hospital Cardiac Arrest study (DANOHCA) Recruiting
  2024-515997-28-00 5 2023-06-16 Patients resuscitated from out-of-hospital cardiac arrest
• Treatment with zoledronate subsequent to denosumab in osteoporosis 2 Recruiting
  2022-502621-17-00 11 2023-05-11 Osteoporosis
• Acute Subcutaneous Semaglutide in Acute Ischemic Stroke (ASSET Trial) Recruiting
  2022-501072-25-02 4 2023-04-12 Ischemic Stroke
• INVITED trial Recruiting
  2022-500906-17-01 4 2023-03-21 Type 1 diabetes
• An open-label, dose-escalation, dose-finding, and proof-of-concept trial of SP-420 in subjects with transfusion-dependent α- or β-thalassemi … Recruiting
  2023-507396-21-00 4 2023-03-16 transfusion-dependent α- or β-thalassemia or low-risk myelodysplastic
• Screening and intervention for subclinical coronary artery disease in patients with type 2 diabetes: THE STENO INTEN-CT STUDY Recruiting
  2022-500143-21-01 6 2023-01-12 Type 2 diabetes
• WOEST-3 Recruiting
  2022-502140-13-00 6 2023-01-11 Atrial fibrillation Acute coronary syndrome Chronic coronary syndrome
• A phase 2 trial on propranolol in combination with pembrolizumab in advanced Angiosarcoma and Undifferentiated Pleomorphic Sarcoma Recruiting
  2024-513727-16-00 4 2022-12-05 Advanced Angiosarcoma and Undifferentiated Pleomorphic Sarcoma
• Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors Recruiting
  2022-500470-33-00 5 2022-11-14 Haemophilia

Showing 241–264 of 582 trials